Five Chinese pet supplement makers target fast-growing global market

Chinese pet health supplement manufacturers are expanding in step with a market projected to reach $4.6 billion by 2033, with one Jiangsu-based company betting on oral dissolvable film technology to stand out. The report profiles five suppliers and highlights the shift toward faster, more convenient delivery formats for companion animals.

Why it matters: - The global pet supplements market was valued at about $2.8 billion in 2025 and is projected to reach $4.6 billion by 2033. - North America holds 48.1% of global revenue, while Asia-Pacific is the fastest-growing region. - Chinese manufacturers are trying to capture more of that growth with new formats, including oral dissolvable films for pets. - Faster-dissolving formats could make supplements easier to give and improve nutrient delivery for pets that resist pills, powders or chews.

What happened: - The report named five China-based pet health supplement manufacturers positioned for 2026 demand. - Wuxi Novohope Biotechnology Co., Ltd. in Wuxi, Jiangsu, was highlighted for oral dissolving membrane health products. - Nanjing Golden Pet Supplies Co., Ltd., Shanghai Hanvet Biomedical Technology Co., Ltd., Shenzhen Hongrui Biotechnology Co., Ltd. and Shanghai Chongxing Pet Products Co., Ltd. were also profiled. - The list was framed around innovative pet nutrition, advanced delivery technologies and global manufacturing capacity.

The details: - Wuxi Novohope says it was established in 2025 and specializes in pet oral dissolving membrane health products. - Novohope says its core technology team comes from the Wahsheer Biotechnology Laboratory at the Chinese University of Hong Kong. - Novohope claims to be the first global brand to release Pet Supplement Oral Dissolvable Films. - The company’s product series include COAT+, EYES+, CALM+, BONE+, HEART+, PROBIO and FIT+. - Novohope says each film is about the size of a postage stamp and dissolves within 10 seconds in saliva. - Novohope says active ingredients are absorbed through the oral mucosa, with a claimed absorption rate of up to 95%. - The company contrasts that with traditional oral supplements, which it says typically achieve around 35% absorption. - Novohope says its facility covers 20,000 square meters and has annual production capacity of 200,000,000 boxes. - Novohope says about 95% of output is exported to Europe, the United States, the United Kingdom, the Middle East, Japan and South Korea. - Novohope says it showed six products at the International Pet Exhibition in Nuremberg, Germany, in May 2026, drawing more than 700 global visitors and over 100 potential client leads. - Novohope says its products completed FDA food registration, received GS1 international product codes and passed SDS and COA testing. - Nanjing Golden Pet Supplies makes powders, tablets and liquid supplements and sells multivitamin blends, joint support formulas and digestive aids. - Nanjing Golden Pet has a distribution network across China and exports to Southeast Asia and Europe. - Shanghai Hanvet Biomedical Technology focuses on veterinary biomedical research and makes high-potency supplements for joint degeneration, urinary health and immune support. - Shanghai Hanvet’s products are commonly recommended by veterinarians and sold through professional channels. - Shenzhen Hongrui Biotechnology makes functional pet treats and chews with active nutrients for oral care, skin and coat, and calming. - Shenzhen Hongrui uses proprietary extrusion and coating techniques and offers ODM/OEM customization for formulations and packaging. - Shanghai Chongxing Pet Products sells soft chews, powders and capsules, with ingredients such as glucosamine, chondroitin and omega-3 fatty acids. - Shanghai Chongxing sells through e-commerce platforms and brick-and-mortar retailers in domestic and international markets.

Between the lines: - Novohope is positioning oral dissolvable film as a response to two persistent industry problems: dosing difficulty and digestive breakdown. - The company’s research-lab tie-up is meant to strengthen its credibility against more established conventional supplement makers. - The other four manufacturers appear better aligned with brands that want established formats and volume supply rather than a new delivery system. - The report suggests suppliers with strong compliance, R&D and export capabilities may have an edge as buyers look for convenience and efficacy.

What's next: - The market is projected to grow at a CAGR of more than 7% through 2031. - Adoption of advanced delivery technologies such as oral dissolvable films is likely to accelerate as demand rises. - Chinese manufacturers are positioned to compete more aggressively in both domestic and export markets. - Buyers are expected to focus on format, regulatory compliance, R&D strength and manufacturing flexibility when choosing partners.

The bottom line: - Conventional supplement makers still dominate volume supply, but oral dissolvable films are emerging as a differentiated category for pet health brands seeking convenience and higher absorption.